US Patent Issued to OSSIO on Aug. 11 for "Subchondral bone defect treatment" (American, Israeli Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,443, issued on Aug. 11, was assigned to OSSIO Ltd (Caesarea, Israel).

"Subchondral bone defect treatment" was invented by Orahn Preiss-Bloom (Zichron Yaakov, Israel) and Brian J. Cole (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "Apparatus and methods are described for treating a subchondral bone defect within a bone of a subject that is adjacent to a joint. A hole is created within the bone extending from a first cortex of the bone to a second cortex of the bone. An implantable device is inserted into the hole such that the implantable device extends from the first cortex of the bone through the subchondral defect and to the second cortex...